Endothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism influences plasma homocysteine concentrations in persons with normal vitamin status

Clinical Chemistry

Volumn 51, Issue 7, 2005, Pages 1159-1164

  Fatini, Cinzia ^a,b   Sofi, Francesco ^a,b   Gori, Anna Maria ^a,b   Sticchi, Elena ^a,b   Marcucci, Rossella ^a,b   Lenti, Meri ^a,b   Casini, Alessandro ^a   Surrenti, Calogero ^a   Abbate, Rosanna ^a,b   Gensini, Gian Franco ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Thrombosis Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; VITAMIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GENE FREQUENCY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING HABIT; BLOOD; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADULT; AGED; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; VITAMIN B 12; VITAMIN B 6; VITAMINS;

EID: 23444438713     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.048850     Document Type: Article

References (30)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway [Review]. N Engl J Med 1993;329:2002-12.
2. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
3. Lefer AM. Nitric oxide: nature's naturally occurring leukocyte inhibitor [Review]. Circulation 1997;95:553-4.
4. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
5. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 1993;334:170-4.
6. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis. John French Lecture 2001 [Review]. Atherosclerosis 2000;154:521-7.
7. Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects [Review]. Am J Med 2002;112:556-65.
8. Danishpajooh IO, Gudi T, Chen Y, Kharitonov VG, Sharma VS, Boss GR. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem 2001;276:27296-303.
9. Juckett MB, Weber M, Balla J, Jacob HS, Vercellotti GM. Nitric oxide donors modulate ferritin and protect endothelium from oxidative injury. Free Radic Biol Med 1996;20:63-73.
10. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW. The Glu298Asp polymorphisms of the NOS3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023-7.
11. Karvonen J, Kauma H, Kervinen K, Rantala M, Ikaheimo M, Paivansalo M, et al. Endothelial nitric oxide synthase gene and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002;251: 102-10.
12. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998;103:65-9.
13. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999;100:1515-20.
14. Brown KS, Kluijtmans LAJ, Young IS, Woodside J, Yarnell JWG, McMaster D, et al. Genetic evidence that nitric oxide modulates homocysteine. The NOS3 894TT genotype is a risk factor for hyperhomocysteinemia. Arterioscler Thromb Vase Biol 2003;23: 1014-20.
15. Heil SG, Den Heijer M, Ven Der Rijt-Pisa BJM, Kluijtmans LAJ, Blom HJ. The 894G>T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels. J Thromb Haemost 2004;2:750-3.
16. Chrysohoou C, Panagiotakos DB, Pitsavos C, Antoniades C, Skoumas J, Brown M, et al. Evidence for association between endothelial nitric oxide synthase gene polymorphism (894G>T) and inflammatory markers: the ATTICA study. Am Heart J 2004; 148:733-8.
17. Nakayama T, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. -786T>C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864-70.
18. Ghilardi G, Biondi ML, De Monti M, Bernini M, Turri O, Massaro F, et al. Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. Clin Chem 2002;48:989-93.
19. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vase Biol 1997;17:3147-53.
20. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190-3.
21. Sofi F, Vecchio S, Giuliani G, Marcucci R, Gori AM, Fedi S, et al. Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the "Florence" diet is not Mediterranean. Eur J Clin Nutr 2005;59:731.
22. ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians. Hypertension 2003;21:1779-86.
23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143-421.
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26(Suppl 1):S5-20.
25. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, et al. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost 1998;79:727-30.
26. Sticchi E, Fatini C, Gensini F, Battaglini B, Alessandrello Liotta A, Abbate R. High-speed detection of the 894G>T polymorphism in the exon 7 of the eNOS gene by real-time fluorescence PCR with the Light-Cycler. Biochem Genet 2004;42:121-7.
27. Hwang JJ, Tsai CT, Yeh HM, Chiang FT, Hsu KL, Tseng CD, et al. The 27-bp tandem repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene is not associated with coronary artery disease in a hospital-based Taiwanese population. Cardiology 2002;97:67-72.
28. Clarke R, Evans JG, Schneede J, Nexo E, Bates C, Fletcher A, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004; 33:34-41.
29. Sues E, Martinez-Lara E, Canuelo A, Sanchez M, Hernandez R, Lopez-Ramos JC, et al. Age-related changes of the nitric oxide system in the rat brain. Brain Res 2002;956:385-92.
30. Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D. Correlation between 677C>T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD [Review]. Am J Cardiovasc Drugs 2001;1:353-61.